Project Adapter CAR-T cells versus AML and AML stem cells

Basic data

Title:
Adapter CAR-T cells versus AML and AML stem cells
Duration:
01/04/2019 to 31/03/2022
Abstract / short description:
Adapter CAR-T cells (AdCAR-T) were developed to facilitate flexible, transient polyimmunotargeting. Within the project multidimensional effector function of AdCAR-T are evaluated in vitro and in vivo. Moreover, immune escape mechanisms are studied and toxicity and reversibility of toxicity is evaluated.

Involved staff

Managers

Faculty of Medicine
University of Tübingen

Contact persons

Faculty of Medicine
University of Tübingen

Local organizational units

Paediatrics Department I and Polyclinic
University Children’s Hospital - Department of Paediatrics
Hospitals and clinical institutes, Faculty of Medicine

Funders

Bonn, Nordrhein-Westfalen, Germany
Help

will be deleted permanently. This cannot be undone.